Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jade Diabetes is an Australian digital health company commercializing a regulated diabetes management platform for people with insulin-treated diabetes and their care teams. Its core product suite includes the Jade mobile and web applications, a health care professional portal, and the My Jade Alexa skill for voice-based insulin dosing and logging. The platform combines dose calculation, blood glucose prediction, coaching, device and app integrations, and remote data sharing to support day-to-day diabetes self-management and telehealth workflows. Jade appears focused on software-enabled diabetes care rather than drug development, with commercial offerings for patients, clinics, payers, camps, and licensing partners. The company emphasizes predictive analytics, insulin-on-board tracking, multi-device interoperability, and broad support for manually entered and connected diabetes data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jade Diabetes.